Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01439750
Title Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Milton S. Hershey Medical Center
Indications

mantle cell lymphoma

Therapies

Bortezomib + Cladribine + Rituximab

Age Groups: adult
Covered Countries USA


No variant requirements are available.